Item 7.01 Regulation FD Disclosure.
Enochian Biosciences Inc., a Delaware corporation (the "Company"), today has
made available an Investor Presentation at the H.C. Wainwright 23rd Annual
Global Investment Conference, during which our Chief Executive Officer, Dr. Mark
Dybul, participated in a webcast. The Investor Presentation is attached to this
Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.
The information included in this Item 7.01 and in Exhibit 99.1 shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), or otherwise subject to the liabilities of that
Section or incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
The Company undertakes no duty or obligation to update or revise information
included in this Report or the Exhibit.
Item 9.01 Financial Statements and Exhibits.
EXHIBIT NO. DESCRIPTION LOCATION
99.1 Investor Presentation Furnished herewith
© Edgar Online, source Glimpses